These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27612038)

  • 41. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.
    Boughter CT; Borowska MT; Guthmiller JJ; Bendelac A; Wilson PC; Roux B; Adams EJ
    Elife; 2020 Nov; 9():. PubMed ID: 33169668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A role of the third complementarity-determining region in the affinity maturation of an antibody.
    Furukawa K; Shirai H; Azuma T; Nakamura H
    J Biol Chem; 2001 Jul; 276(29):27622-8. PubMed ID: 11375987
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Display of somatostatin-related peptides in the complementarity determining regions of an antibody light chain.
    Simon PJ; Brogle KC; Wang B; Kyle DJ; Soltis DA
    Arch Biochem Biophys; 2005 Aug; 440(2):148-57. PubMed ID: 16051181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.
    Wakankar AA; Borchardt RT; Eigenbrot C; Shia S; Wang YJ; Shire SJ; Liu JL
    Biochemistry; 2007 Feb; 46(6):1534-44. PubMed ID: 17279618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity.
    Timmerman P; Barderas R; Desmet J; Altschuh D; Shochat S; Hollestelle MJ; Höppener JW; Monasterio A; Casal JI; Meloen RH
    J Biol Chem; 2009 Dec; 284(49):34126-34. PubMed ID: 19808684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro affinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay.
    Xia L; Zhang J; Cui C; Bi X; Xiong J; Yu H; An Z; Luo W; Xia N
    J Biochem; 2015 Dec; 158(6):531-8. PubMed ID: 26163519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis of affinity maturation of the TEPC15/Vkappa45.1 anti-2-phenyl-5-oxazolone antibodies.
    Scotti C; Gherardi E
    J Mol Biol; 2006 Jun; 359(5):1161-9. PubMed ID: 16682055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.
    Dai K; Khan SN; Wang Y; He L; Guenaga J; Ingale J; Sundling C; O'Dell S; McKee K; Phad G; Corcoran M; Wilson R; Mascola JR; Zhu J; Li Y; Karlsson Hedestam GB; Wyatt RT
    Sci Rep; 2016 Feb; 6():20987. PubMed ID: 26879974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asparagine Deamidation in a Complementarity Determining Region of a Recombinant Monoclonal Antibody in Complex with Antigen.
    Nowak C; Tiwari A; Liu H
    Anal Chem; 2018 Jun; 90(11):6998-7003. PubMed ID: 29712431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving antibody binding affinity and specificity for therapeutic development.
    Bostrom J; Lee CV; Haber L; Fuh G
    Methods Mol Biol; 2009; 525():353-76, xiii. PubMed ID: 19252851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan.
    Tsui P; Higazi DR; Wu Y; Dunmore R; Solier E; Kasali T; Bond NJ; Huntington C; Carruthers A; Hood J; Borrok MJ; Barnes A; Rickert K; Phipps S; Shirinian L; Zhu J; Bowen MA; Dall'Acqua W; Murray LA
    MAbs; 2017 Jan; 9(1):104-113. PubMed ID: 27834568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity.
    Rehder DS; Chelius D; McAuley A; Dillon TM; Xiao G; Crouse-Zeineddini J; Vardanyan L; Perico N; Mukku V; Brems DN; Matsumura M; Bondarenko PV
    Biochemistry; 2008 Feb; 47(8):2518-30. PubMed ID: 18232715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions.
    Dekker LJ; Zeneyedpour L; Brouwer E; van Duijn MM; Sillevis Smitt PA; Luider TM
    Anal Bioanal Chem; 2011 Jan; 399(3):1081-91. PubMed ID: 21107826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SDR grafting--a new approach to antibody humanization.
    Kashmiri SV; De Pascalis R; Gonzales NR; Schlom J
    Methods; 2005 May; 36(1):25-34. PubMed ID: 15848072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.
    Monnet C; Bettsworth F; Stura EA; Le Du MH; Ménez R; Derrien L; Zinn-Justin S; Gilquin B; Sibaï G; Battail-Poirot N; Jolivet M; Ménez A; Arnaud M; Ducancel F; Charbonnier JB
    J Mol Biol; 2002 Jan; 315(4):699-712. PubMed ID: 11812141
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies.
    Timm V; Gruber P; Wasiliu M; Lindhofer H; Chelius D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(9-10):777-84. PubMed ID: 20153988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.